MALLORY BLESSINGER: Open Payments
NPI 1164154621 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $219 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $79 |
| Lundbeck LLC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, REXULTI, COBENFY, UZEDY, Qelbree, VRAYLAR, CAPLYTA, Auvelity.
Industry payments across IN — which companies pay providers there.
